NYSE:PHG - Koninklijke Philips Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$44.99
▲ +1.79 (4.14%)

This chart shows the closing price for PHG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Koninklijke Philips Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHG

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 12 analysts offering 12 month price targets for Koninklijke Philips in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $44.99.

This chart shows the closing price for PHG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 12 contributing investment analysts is to buy stock in Koninklijke Philips. This rating has held steady since August 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
4/22/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
7/21/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/19/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/19/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldN/A
9/10/2021BarclaysReiterated RatingOverweightLow
9/8/2021Jefferies Financial GroupInitiated CoverageBuyLow
8/31/2021ING GroupUpgradeHold ➝ BuyLow
8/4/2021Morgan StanleyReiterated RatingOverweightLow
7/28/2021UBS GroupReiterated RatingBuyLow
7/28/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldLow
7/28/2021Bank of AmericaDowngradeBuy ➝ NeutralLow
7/28/2021Oddo BhfUpgradeNeutral ➝ OutperformLow
7/8/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldLow
6/29/2021BarclaysReiterated RatingOverweightLow
6/21/2021HSBCDowngradeBuy ➝ HoldLow
4/29/2021Berenberg BankReiterated RatingBuyLow
4/28/2021Credit Suisse GroupReiterated RatingNeutralLow
4/27/2021UBS GroupReiterated RatingBuyLow
3/23/2021BarclaysReiterated RatingOverweightMedium
3/18/2021JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
1/26/2021Credit Suisse GroupReiterated RatingNeutralHigh
1/26/2021JPMorgan Chase & Co.Reiterated RatingNeutralHigh
1/26/2021UBS GroupReiterated RatingBuyHigh
1/20/2021Berenberg BankReiterated RatingBuyLow
1/19/2021JPMorgan Chase & Co.Reiterated RatingNeutralLow
11/12/2020Berenberg BankReiterated RatingBuyLow
10/29/2020Morgan StanleyReiterated RatingOverweightLow
10/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
10/20/2020UBS GroupReiterated RatingBuyLow
10/20/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
10/2/2020UBS GroupReiterated RatingBuyLow
9/23/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
9/23/2020BarclaysReiterated RatingOverweightLow
9/3/2020JPMorgan Chase & Co.Reiterated RatingNeutralHigh
9/1/2020UBS GroupReiterated RatingBuyMedium
8/27/2020Societe GeneraleDowngradeSellLow
7/28/2020Societe GeneraleInitiated CoverageBuyMedium
7/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/9/2020Morgan StanleyReiterated RatingOverweightLow
6/22/2020BarclaysReiterated RatingOverweightLow
4/22/2020Morgan StanleyReiterated RatingOverweightLow
4/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralMedium
4/19/2020Kepler Capital MarketsReiterated RatingHoldHigh
4/7/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
3/23/2020DZ BankReiterated RatingHold ➝ BuyHigh
3/23/2020UBS GroupReiterated RatingBuyLow
3/10/2020Kepler Capital MarketsReiterated RatingHoldMedium
2/10/2020UBS GroupReiterated RatingBuyLow
1/21/2020Roth CapitalReiterated RatingBuyMedium
1/13/2020Bank of AmericaBoost Price TargetBuy$45.00 ➝ $51.00Low
12/6/2019Morgan StanleyUpgradeEqual Weight ➝ OverweightMedium
10/28/2019Berenberg BankReiterated RatingBuyMedium
10/7/2019Berenberg BankReiterated RatingBuyLow
8/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/30/2019CitigroupInitiated CoverageBuy ➝ BuyLow
10/2/2018Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
9/18/2018Exane BNP ParibasUpgradeNeutral ➝ OutperformLow
9/17/2018BNP ParibasUpgradeHold ➝ BuyLow
9/13/2018Sanford C. BernsteinInitiated CoverageOutperformLow
4/17/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
2/12/2018Berenberg BankUpgradeHold ➝ BuyLow
11/9/2017JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralN/A
10/24/2017CitigroupReiterated RatingBuyN/A
10/16/2017BNP ParibasDowngradeOutperform ➝ NeutralN/A
7/24/2017JPMorgan Chase & Co.Reiterated RatingBuyLow
7/3/2017Canaccord GenuityReiterated RatingBuy$37.00Low
6/21/2017NatixisDowngradeBuy ➝ NeutralLow
6/20/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldMedium
4/25/2017Societe GeneraleDowngradeBuy ➝ HoldLow
3/21/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
2/7/2017Berenberg BankInitiated CoverageHoldN/A
1/26/2017CitigroupReiterated RatingBuyN/A
12/12/2016Morgan StanleyDowngradeOverweight ➝ Equal WeightN/A
11/23/2016CitigroupInitiated CoverageBuyN/A
10/24/2016Credit Suisse GroupReiterated RatingBuy$30.00N/A
(Data available from 10/19/2016 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2021
  • 8 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/21/2021
  • 11 very positive mentions
  • 7 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
8/20/2021
  • 13 very positive mentions
  • 10 positive mentions
  • 11 negative mentions
  • 6 very negative mentions
9/19/2021
  • 14 very positive mentions
  • 20 positive mentions
  • 11 negative mentions
  • 9 very negative mentions
10/19/2021

Current Sentiment

  • 14 very positive mentions
  • 20 positive mentions
  • 11 negative mentions
  • 9 very negative mentions

Recent Stories by Sentiment

Koninklijke Philips logo
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Re
Read More

Today's Range

Now: $44.99
Low: $43.89
High: $45.06

50 Day Range

MA: $45.31
Low: $43.03
High: $48.55

52 Week Range

Now: $44.99
Low: $42.47
High: $61.23

Volume

53,522 shs

Average Volume

779,506 shs

Market Capitalization

$40.73 billion

P/E Ratio

34.08

Dividend Yield

1.97%

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Koninklijke Philips?

The following equities research analysts have issued research reports on Koninklijke Philips in the last year: Bank of America Co., Barclays PLC, Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, ING Group, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Oddo Bhf, TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for PHG.

What is the current price target for Koninklijke Philips?

0 Wall Street analysts have set twelve-month price targets for Koninklijke Philips in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Koninklijke Philips in the next year.
View the latest price targets for PHG.

What is the current consensus analyst rating for Koninklijke Philips?

Koninklijke Philips currently has 4 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHG will outperform the market and that investors should add to their positions of Koninklijke Philips.
View the latest ratings for PHG.

What other companies compete with Koninklijke Philips?

Other companies that are similar to Koninklijke Philips include Hologic, Butterfly Network, Nano-X Imaging, HealthCor Catalio Acquisition and Check-Cap.

How do I contact Koninklijke Philips' investor relations team?

Koninklijke Philips' physical mailing address is PHILIPS CENTER AMSTELPLEIN 2, AMSTERDAM P7, 1096 BC. The technology company's listed phone number is (120) 597-7777 and its investor relations email address is [email protected] The official website for Koninklijke Philips is www.philips.com.